Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LINE Lineage

盘后交易 01-07 19:41:56 EST

35.08

-0.97

-2.69%

盘后35.08

+0.000.00%

16:20 EST

最高36.56	最低34.98	成交量73.21万
今开36.22	昨收36.05	日振幅4.38%
总市值80.08亿	流通市值20.22亿	总股本2.28亿
成交额2,587万	换手率1.27%	流通股本5,764万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LINE","market":"US","secType":"STK","nameCN":"Lineage","latestPrice":35.08,"timestamp":1767819600000,"preClose":36.05,"halted":0,"volume":732103,"hourTrading":{"tag":"盘后","latestPrice":35.08,"preClose":35.08,"latestTime":"16:20 EST","volume":23673,"amount":830448.84,"timestamp":1767820800574},"delay":0,"floatShares":57642784,"shares":228289625,"eps":-0.794135,"marketStatus":"盘后交易","change":-0.97,"latestTime":"01-07 19:41:56 EST","open":36.22,"high":36.56,"low":34.98,"amount":25873296.04918,"amplitude":0.043828,"askPrice":44.5,"askSize":100,"bidPrice":34.73,"bidSize":12,"shortable":3,"etf":0,"ttmEps":-0.794135,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1767834000000},"marketStatusCode":4,"adr":0,"listingDate":1721880000000,"exchange":"NASDAQ","adjPreClose":36.05,"dividendRate":0.060117,"preHourTrading":{"tag":"盘前","latestPrice":36.36,"preClose":36.05,"latestTime":"09:28 EST","volume":93,"amount":3382.47324,"timestamp":1767796113041},"postHourTrading":{"tag":"盘后","latestPrice":35.08,"preClose":35.08,"latestTime":"16:20 EST","volume":23673,"amount":830448.84,"timestamp":1767820800574},"volumeRatio":0.4356,"impliedVol":0.4152,"impliedVolPercentile":0.588},"requestUrl":"/m/hq/s/LINE","defaultTab":"news","newsList":[{"id":"2577430291","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大跌5.15%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577430291","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577430291?lang=zh_cn&edition=full","pubTime":"2025-10-22 22:25","pubTimestamp":1761143102,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日22时25分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅跳水5.15%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022222503a6c83615&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022222503a6c83615&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LCTX","BK4224","BK4539","BK4007","LINE"],"gpt_icon":0},{"id":"2569475758","title":"Lineage Cell Therapeutics, Inc.盘中异动 大幅拉升5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569475758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569475758?lang=zh_cn&edition=full","pubTime":"2025-09-23 01:16","pubTimestamp":1758561418,"startTime":"0","endTime":"0","summary":"北京时间2025年09月23日01时16分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅拉升5.56%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。其相关个股中，Qualigen Therapeutics, Inc.、Mbx Biosciences, Inc.、Metsera, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Onconetix, Inc.、Mbx Biosciences, Inc.较为活跃，换手率分别为3187.70%、158.30%、67.32%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Mbx Biosciences, Inc.、Kodiak Sciences Inc，振幅分别为144.19%、86.84%、43.65%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923011658a43cdab0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923011658a43cdab0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LINE","BK4539","BK4224","LCTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2568226095","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568226095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568226095?lang=zh_cn&edition=full","pubTime":"2025-09-19 21:59","pubTimestamp":1758290351,"startTime":"0","endTime":"0","summary":"北京时间2025年09月19日21时59分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅下跌5.09%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Alx Oncology Holdings Inc.、Clearmind Medicine Inc.涨幅较大，Clearmind Medicine Inc.、Adaptimmune Therapeutics Plc、Aptevo Therapeutics Inc.较为活跃，换手率分别为579.31%、89.35%、76.17%，振幅较大的相关个股有Adaptimmune Therapeutics Plc、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Alx Oncology Holdings Inc.，振幅分别为25.75%、24.93%、20.18%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919215911a72a6f0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919215911a72a6f0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LCTX","BK4224","BK4139","BK4539","BK4007","LINE"],"gpt_icon":0},{"id":"1152457993","title":"Lineage与新奥尔良港合作扩建保税仓储空间，助力全球贸易流通","url":"https://stock-news.laohu8.com/highlight/detail?id=1152457993","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152457993?lang=zh_cn&edition=full","pubTime":"2025-08-22 05:01","pubTimestamp":1755810076,"startTime":"0","endTime":"0","summary":"Lineage与新奥尔良港合作扩建保税仓储空间，助力全球贸易流通","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE","BK4224"],"gpt_icon":0},{"id":"2559960910","title":"8月14日中船集团广船国际联合中船贸易为韩国H-LINE航运公司建造的8600车双燃料汽车运输船（PCTC）2号船签字交","url":"https://stock-news.laohu8.com/highlight/detail?id=2559960910","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559960910?lang=zh_cn&edition=full","pubTime":"2025-08-15 07:05","pubTimestamp":1755212737,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LINE","BK4224"],"gpt_icon":0},{"id":"2558665056","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨6.66%报1.050美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558665056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558665056?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:44","pubTimestamp":1754919856,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时44分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升6.66%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.较为活跃，换手率分别为2598.16%、259.43%、82.15%，振幅较大的相关个股有Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.，振幅分别为74.27%、69.75%、20.72%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112144169740e8bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112144169740e8bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4539","LCTX","LENZ","LINE","BK4224"],"gpt_icon":0},{"id":"2557301828","title":"Lineage Cell Therapeutics, Inc.盘中异动 快速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557301828","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557301828?lang=zh_cn&edition=full","pubTime":"2025-08-07 02:16","pubTimestamp":1754504164,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日02时16分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速上涨5.26%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Biomx Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Rigel Pharmaceuticals, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为723.43%、604.52%、101.55%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Biomx Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为57.18%、51.84%、48.52%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508070216049737ef84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508070216049737ef84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LCTX","BK4224","BK4539","BK4007","LINE"],"gpt_icon":0},{"id":"2557352092","title":"韩国船企联合开发AI自主与环保船舶技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2557352092","media":"国际船舶网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557352092?lang=zh_cn&edition=full","pubTime":"2025-08-05 13:23","pubTimestamp":1754371412,"startTime":"0","endTime":"0","summary":"近日，HD现代集团旗下的HD韩国造船海洋、HD现代海洋解决方案、Avikus与韩国船东H-Line签署四方战略合作协议。根据协议，四方将联合开发基于人工智能的自主与环保船舶技术，最大限度地提升船舶及船队运营的整体效率。HD韩国造船海洋未来技术研究院院长张光弼表示：“此次合作是打破造船与航运行业界限、推动基于AI的数字化创新的起点。这将成为引领环保未来船舶标准的重要里程碑。”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805132908a6d3c528&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805132908a6d3c528&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4567","IE00BZ1G4Q59.USD","HD","LU1778281490.HKD","IE00BSNM7G36.USD","IE00B1XK9C88.USD","BK4224","LU1989772840.SGD","LU0823434740.USD","LU0234572021.USD","LU0868494708.USD","LU1989772923.USD","LINE","LU2756315664.SGD","LU1162221912.USD","BK4550","LU1496350171.SGD","IE00BWXC8680.SGD","LU1496350502.SGD","BK4585","BK4213","LU1069344957.HKD","LU0079474960.USD","BK4581","LU0823411888.USD","IE00BKVL7J92.USD","LU1035775433.USD","BK4588","LU1674673691.USD","LU1093756168.USD","AR","LU0942090050.USD","BK4504","BK4534","BK4566","LU1674673428.USD","BK4201","LU0943347566.SGD","LU0868494617.USD","LU0354030511.USD","LU1551013342.USD","LU0820561818.USD","LU0820561909.HKD","LU0823434583.USD","LU1551013425.SGD","LU0238689110.USD","LU0354030438.USD","LU0689472784.USD","IMO","BK4533"],"gpt_icon":0},{"id":"2556453228","title":"Lineage Cell Therapeutics, Inc.盘中异动 临近收盘急速跳水5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556453228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556453228?lang=zh_cn&edition=full","pubTime":"2025-08-02 03:53","pubTimestamp":1754077998,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日03时53分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速下跌5.25%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Equillium, Inc.、4D Molecular Therapeutics, Inc.、Sensei Biotherapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Equillium, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为1785.52%、384.54%、308.60%，振幅较大的相关个股有Equillium, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、天境生物，振幅分别为253.15%、72.18%、59.20%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802035318a470429f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802035318a470429f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","BK4139","LENZ","LINE","BK4007","LCTX","BK4539"],"gpt_icon":0},{"id":"2555099029","title":"Lineage Cell Therapeutics, Inc.盘中异动 临近收盘快速跳水6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555099029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555099029?lang=zh_cn&edition=full","pubTime":"2025-07-31 03:40","pubTimestamp":1753904441,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日03时40分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速跳水6.07%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731034041a6ca25e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731034041a6ca25e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LINE","BK4539","BK4224","LCTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2554341770","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.31%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554341770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554341770?lang=zh_cn&edition=full","pubTime":"2025-07-28 22:19","pubTimestamp":1753712380,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日22时19分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升5.31%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃，换手率分别为313.11%、160.72%、109.68%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为102.74%、75.82%、71.61%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822194097235e56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822194097235e56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE","LCTX","BK4007","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2552455500","title":"CStar Line开通连接中国与红海的新航线FRS1","url":"https://stock-news.laohu8.com/highlight/detail?id=2552455500","media":"华光源海","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552455500?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:12","pubTimestamp":1752801175,"startTime":"0","endTime":"0","summary":"CStar Line将开通连接中国与红海的新航线FRS1，7月26日首航。集运企业CStar Line将开通一条连接中国与红海的新航线FRS1，计划7月26日首航，首航船为1831TEU的“CSTAR VOYAGER”轮。媒体相关报道据了解，CStar Line总部位于迪拜，提供远东、印度、中东、地中海、黑海和波罗的海之间的集运服务，同时还提供多式联运解决方案。中国常驻联合国副代表耿爽也在会上表示，呼吁胡塞武装尊重各国商船，根据国际法在红海水域的航行权利，停止袭击商船，维护红海水域航道安全。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718102117a45248df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718102117a45248df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224"],"gpt_icon":0},{"id":"2551947061","title":"Lineage Cell Therapeutics, Inc.盘中异动 临近收盘急速下跌5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551947061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551947061?lang=zh_cn&edition=full","pubTime":"2025-07-16 03:43","pubTimestamp":1752608634,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日03时43分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速下挫5.51%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.12%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Cyclacel Pharmaceuticals, Inc.、Polyrizon Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3810.84%、2220.11%、1568.97%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.，振幅分别为444.11%、116.77%、75.50%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716034354a44cf94f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716034354a44cf94f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LINE","BK4539","BK4224","LCTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2551844311","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551844311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551844311?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:49","pubTimestamp":1752500979,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时49分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速上涨5.34%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Promis Neurosciences Inc.、Dare Bioscience, Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为1731.80%、593.92%、459.18%，振幅较大的相关个股有Promis Neurosciences Inc.、Dare Bioscience, Inc.、Biomx Inc.，振幅分别为163.93%、100.99%、87.78%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071421493997a5c14f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071421493997a5c14f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4007","BK4224","LENZ","BK4139","BK4539","LCTX"],"gpt_icon":0},{"id":"1166565406","title":"Lineage Cell Therapeutics 2024年第四季度GAAP每股收益$(0.02) 超过预期$(0.03)，销售额$2.900百万 超预期$1.621百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1166565406","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166565406?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:08","pubTimestamp":1741637306,"startTime":"0","endTime":"0","summary":"公司报告季度销售额$2.900百万，超过了分析师共识预估的$1.621百万，提高了78.88%。与去年同期的销售额$2.100百万相比，这一数字增长了38.10%。以上内容来自Benzinga Earnings专栏，原文如下：$Lineage$ Cell $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 33.33 percent. This is a 33.33 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $2.900 million which beat the analyst consensus estimate of $1.621 million by 78.88 percent.  This is a 38.10 percent","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","LINE","LCTX"],"gpt_icon":0},{"id":"2518220660","title":"Scotiabank：维持Lineage(LINE.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由73.00美元调整至74.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220660","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518220660?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:02","pubTimestamp":1741629758,"startTime":"0","endTime":"0","summary":"Scotiabank：维持Lineage(LINE.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由73.00美元调整至74.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11020248641749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LINE"],"gpt_icon":0},{"id":"2518527621","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘快速上涨7.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518527621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518527621?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:39","pubTimestamp":1741613947,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时39分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速上涨7.06%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为487.59%、74.68%、56.14%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为34.57%、28.59%、25.35%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213908964037cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213908964037cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4224","LINE","BK4139","LENZ"],"gpt_icon":0},{"id":"2517160017","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.53%报0.548美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517160017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517160017?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:51","pubTimestamp":1741279881,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时51分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升5.53%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307005121989ece5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307005121989ece5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","BK4139","LCTX","LINE","LENZ"],"gpt_icon":0},{"id":"2517028306","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517028306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517028306?lang=zh_cn&edition=full","pubTime":"2025-03-05 01:32","pubTimestamp":1741109577,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日01时32分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.02%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305013257a25f3654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305013257a25f3654&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LCTX","BK4139","LINE","BK4224"],"gpt_icon":0},{"id":"2516344637","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大跌5.24%报0.532美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516344637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516344637?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:05","pubTimestamp":1741014302,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时05分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅下挫5.24%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1039.63%、125.32%、100.95%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为163.15%、70.53%、48.34%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230502a25d4a2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230502a25d4a2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LCTX","BK4139","BK4224","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onelineage.com","stockEarnings":[{"period":"1week","weight":0.0149},{"period":"1month","weight":0.0204},{"period":"3month","weight":-0.1182},{"period":"6month","weight":-0.163},{"period":"1year","weight":-0.3877},{"period":"ytd","weight":0.03}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":0.0089},{"period":"3month","weight":0.0278},{"period":"6month","weight":0.1054},{"period":"1year","weight":0.162},{"period":"ytd","weight":0.0145}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lineage, Inc.于2017年在马里兰州成立，是世界上最大的全球温度控制仓库房地产投资信托基金，拥有现代化和战略性的房地产网络。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.009942},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.051794},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.047075},{"month":4,"riseRate":0.909091,"avgChangeRate":0.072457},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.085175},{"month":6,"riseRate":0.7,"avgChangeRate":0.017118},{"month":7,"riseRate":0.6,"avgChangeRate":-0.034691},{"month":8,"riseRate":0.2,"avgChangeRate":-0.040778},{"month":9,"riseRate":0.4,"avgChangeRate":-0.041279},{"month":10,"riseRate":0.7,"avgChangeRate":0.025106},{"month":11,"riseRate":0.4,"avgChangeRate":-0.07115},{"month":12,"riseRate":0.6,"avgChangeRate":-0.044918}],"exchange":"NASDAQ","name":"Lineage","nameEN":"Lineage"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lineage(LINE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lineage,LINE,Lineage股票,Lineage股票老虎,Lineage股票老虎国际,Lineage行情,Lineage股票行情,Lineage股价,Lineage股市,Lineage股票价格,Lineage股票交易,Lineage股票购买,Lineage股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lineage(LINE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}